Premature ovarian failure

被引:39
作者
Meskhi, Apollo [1 ]
Seif, Mourad W. [1 ]
机构
[1] Univ Manchester, St Marys Hosp, Acad Unit Obs & Gynae, Manchester M13 0JH, Lancs, England
关键词
hormonal (oestrogen) therapy; oestrogen deficiency; ovarian function; ovarian reserve; premature ovarian failure;
D O I
10.1097/01.gco.0000233937.36554.d3
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Purpose of review To summarize current knowledge about premature ovarian failure (POF) with an emphasis on recent developments regarding its management. Recent findings The incidence of POF is increasing largely due to improved survival rates of cancer patients treated with radiation and chemotherapy. Delayed diagnosis and management of POF leads to suboptimal outcomes. Anticipation and early detection of this condition in high-risk women by means of ovarian function testing, followed by early institution of appropriate management could improve outcomes. Choice of strategies should vary depending on the age of onset, associated symptoms and fertility aspirations of the individual, and should change with the patient's advancing age. Summary Early assessment of the individual's risk of developing POF, development of a strategic management plan, and timely commencement of infertility and hormone deficiency treatment, together with counselling in an integrated management plan should improve both the short and long-term health of those with POF.
引用
收藏
页码:418 / 426
页数:9
相关论文
共 161 条
[1]   An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains [J].
Aaltonen, J ;
Bjorses, P ;
Perheentupa, J ;
HorelliKuitunen, N ;
Palotie, A ;
Peltonen, L ;
Lee, YS ;
Francis, F ;
Hennig, S ;
Thiel, C ;
Lehrach, H ;
Yaspo, ML .
NATURE GENETICS, 1997, 17 (04) :399-403
[2]   CLINICAL VARIATION OF AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY (APECED) IN A SERIES OF 68 PATIENTS [J].
AHONEN, P ;
MYLLARNIEMI, S ;
SIPILA, I ;
PERHEENTUPA, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (26) :1829-1836
[3]   THE EXPRESSION OF AUTOIMMUNE POLYGLANDULAR DISEASE TYPE-I APPEARS ASSOCIATED WITH SEVERAL HLA-A ANTIGENS BUT NOT WITH HLA-DR [J].
AHONEN, P ;
KOSKIMIES, S ;
LOKKI, ML ;
TIILIKAINEN, A ;
PERHEENTUPA, J .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1988, 66 (06) :1152-1157
[4]  
AIMAN J, 1985, OBSTET GYNECOL, V66, P9
[5]   Clinical features of primary ovarian failure caused by a point mutation in the follicle-stimulating hormone receptor gene [J].
Aittomaki, K ;
Herva, R ;
Stenman, UH ;
Juntunen, K ;
Ylostalo, P ;
Hovatta, O ;
delaChapelle, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (10) :3722-3726
[6]   MUTATION IN THE FOLLICLE-STIMULATING-HORMONE RECEPTOR GENE CAUSES HEREDITARY HYPERGONADOTROPIC OVARIAN FAILURE [J].
AITTOMAKI, K ;
LUCENA, JLD ;
PAKARINEN, P ;
SISTONEN, P ;
TAPANAINEN, J ;
GROMOLL, J ;
KASKIKARI, R ;
SANKILA, EM ;
LEHVASLAIHO, H ;
ENGEL, AR ;
NIESCHLAG, E ;
HUHTANIEMI, I ;
DELACHAPELLE, A .
CELL, 1995, 82 (06) :959-968
[7]   PREGNANCIES AFTER PREMATURE OVARIAN FAILURE [J].
ALPER, MM ;
JOLLY, EE ;
GARNER, PR .
OBSTETRICS AND GYNECOLOGY, 1986, 67 (03) :S59-S62
[8]   Bone loss in young women with karyotypically normal spontaneous premature ovarian failure [J].
Anasti, JN ;
Kalantaridou, SN ;
Kimzey, LM ;
Defensor, RA ;
Nelson, LM .
OBSTETRICS AND GYNECOLOGY, 1998, 91 (01) :12-15
[9]   Dehydroepiandrosterone replacement therapy [J].
Arlt, W .
SEMINARS IN REPRODUCTIVE MEDICINE, 2004, 22 (04) :379-388
[10]   Management of the androgen-deficient woman [J].
Arlt, W .
GROWTH HORMONE & IGF RESEARCH, 2003, 13 :S85-S89